These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 26883200)

  • 1. SREBP-2 promotes stem cell-like properties and metastasis by transcriptional activation of c-Myc in prostate cancer.
    Li X; Wu JB; Li Q; Shigemura K; Chung LW; Huang WC
    Oncotarget; 2016 Mar; 7(11):12869-84. PubMed ID: 26883200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PSCA promotes prostate cancer proliferation and cell-cycle progression by up-regulating c-Myc.
    Li E; Liu L; Li F; Luo L; Zhao S; Wang J; Kang R; Luo J; Zhao Z
    Prostate; 2017 Dec; 77(16):1563-1572. PubMed ID: 28971496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells.
    Ren D; Wang M; Guo W; Huang S; Wang Z; Zhao X; Du H; Song L; Peng X
    Cell Tissue Res; 2014 Dec; 358(3):763-78. PubMed ID: 25296715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of SREBP inhibits tumor growth and initiation by altering cellular metabolism in colon cancer.
    Wen YA; Xiong X; Zaytseva YY; Napier DL; Vallee E; Li AT; Wang C; Weiss HL; Evers BM; Gao T
    Cell Death Dis; 2018 Feb; 9(3):265. PubMed ID: 29449559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CIP2A mediates prostate cancer progression via the c-Myc signaling pathway.
    Guo Z; Liu D; Su Z
    Tumour Biol; 2015 Jun; 36(6):4777-83. PubMed ID: 25636449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations.
    Li X; Wu JB; Chung LW; Huang WC
    Oncotarget; 2015 Dec; 6(38):41018-32. PubMed ID: 26512780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BTF3 sustains cancer stem-like phenotype of prostate cancer via stabilization of BMI1.
    Hu J; Sun F; Chen W; Zhang J; Zhang T; Qi M; Feng T; Liu H; Li X; Xing Y; Xiong X; Shi B; Zhou G; Han B
    J Exp Clin Cancer Res; 2019 May; 38(1):227. PubMed ID: 31138311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNAi-mediated silencing of Myc transcription inhibits stem-like cell maintenance and tumorigenicity in prostate cancer.
    Civenni G; Malek A; Albino D; Garcia-Escudero R; Napoli S; Di Marco S; Pinton S; Sarti M; Carbone GM; Catapano CV
    Cancer Res; 2013 Nov; 73(22):6816-27. PubMed ID: 24063893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HN1L promotes stem cell-like properties by regulating TGF-β signaling pathway through targeting FOXP2 in prostate cancer.
    Nong S; Wang Z; Wei Z; Ma L; Guan Y; Ni J
    Cell Biol Int; 2022 Jan; 46(1):83-95. PubMed ID: 34519127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of SOX18 promotes prostate cancer progression via the regulation of TCF1, c-Myc, cyclin D1 and MMP-7.
    Yin H; Sheng Z; Zhang X; Du Y; Qin C; Liu H; Dun Y; Wang Q; Jin C; Zhao Y; Xu T
    Oncol Rep; 2017 Feb; 37(2):1045-1051. PubMed ID: 27922675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy.
    Mukha A; Kahya U; Linge A; Chen O; Löck S; Lukiyanchuk V; Richter S; Alves TC; Peitzsch M; Telychko V; Skvortsov S; Negro G; Aschenbrenner B; Skvortsova II; Mirtschink P; Lohaus F; Hölscher T; Neubauer H; Rivandi M; Labitzky V; Lange T; Franken A; Behrens B; Stoecklein NH; Toma M; Sommer U; Zschaeck S; Rehm M; Eisenhofer G; Schwager C; Abdollahi A; Groeben C; Kunz-Schughart LA; Baretton GB; Baumann M; Krause M; Peitzsch C; Dubrovska A
    Theranostics; 2021; 11(16):7844-7868. PubMed ID: 34335968
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Huang SY; Huang GJ; Wu HC; Kao MC; Huang WC
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30301150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NCAPG2 promotes prostate cancer malignancy and stemness via STAT3/c-MYC signaling.
    Zhang E; Chen Z; Liu W; Lin L; Wu L; Guan J; Wang J; Kong C; Bi J; Zhang M
    J Transl Med; 2024 Jan; 22(1):12. PubMed ID: 38166947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A reciprocal regulatory circuit between CD44 and FGFR2 via c-myc controls gastric cancer cell growth.
    Park J; Kim SY; Kim HJ; Kim KM; Choi EY; Kang MS
    Oncotarget; 2016 May; 7(19):28670-83. PubMed ID: 27107424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A regulatory circuit HP1γ/miR-451a/c-Myc promotes prostate cancer progression.
    Chang C; Liu J; He W; Qu M; Huang X; Deng Y; Shen L; Zhao X; Guo H; Jiang J; Fu XY; Huang R; Zhang D; Yan J
    Oncogene; 2018 Jan; 37(4):415-426. PubMed ID: 28967902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An actionable sterol-regulated feedback loop modulates statin sensitivity in prostate cancer.
    Longo J; Mullen PJ; Yu R; van Leeuwen JE; Masoomian M; Woon DTS; Wang Y; Chen EX; Hamilton RJ; Sweet JM; van der Kwast TH; Fleshner NE; Penn LZ
    Mol Metab; 2019 Jul; 25():119-130. PubMed ID: 31023626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-143 and miR-145 inhibit stem cell characteristics of PC-3 prostate cancer cells.
    Huang S; Guo W; Tang Y; Ren D; Zou X; Peng X
    Oncol Rep; 2012 Nov; 28(5):1831-7. PubMed ID: 22948942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FZD8, a target of p53, promotes bone metastasis in prostate cancer by activating canonical Wnt/β-catenin signaling.
    Li Q; Ye L; Zhang X; Wang M; Lin C; Huang S; Guo W; Lai Y; Du H; Li J; Song L; Peng X
    Cancer Lett; 2017 Aug; 402():166-176. PubMed ID: 28602974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway.
    Hsieh IS; Chang KC; Tsai YT; Ke JY; Lu PJ; Lee KH; Yeh SD; Hong TM; Chen YL
    Carcinogenesis; 2013 Mar; 34(3):530-8. PubMed ID: 23188675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospholipase Cε Regulates Prostate Cancer Lipid Metabolism and Proliferation by Targeting AMP-Activated Protein Kinase (AMPK)/Sterol Regulatory Element-Binding Protein 1 (SREBP-1) Signaling Pathway.
    Zheng Y; Jin J; Gao Y; Luo C; Wu X; Liu J
    Med Sci Monit; 2020 Jul; 26():e924328. PubMed ID: 32696762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.